Securing a Competitive Advantage in the Reverse Transcriptase Market

Report #06-007
Publication Date: March 2006
Page Count: 126

Print Copy: ~~$4,000~~ $500
Company-wide Electronic Copy (includes print copy): ~~$6,000~~ $500
plus Data Set: an additional $1,200

Brief Description

Executive Summary

Questionnaire

Respondent Insights

Order Form

Securing a Competitive Advantage in the Reverse Transcriptase Market provides insight into customer behavior, brand warfare, pricing strategy, and market growth potential in this complex and important market.

From a product strategy perspective, reverse transcriptase is critical because it serves as an entry point into a supplier’s profitable kits and reagents (as well as instrumentation) for the RT-PCR and real-time PCR markets. Dominance in such an important market foothold can secure a key competitive advantage for a supplier. However worthwhile, attaining and maintaining such a position in the reverse transcriptase market is difficult due to the presence of several key players. An effective competitive strategy requires a thorough and nuanced understanding of market dynamics that this study is designed to provide.

Based upon a 24-question survey of over 500 life scientist customers in the North American market for reverse transcriptase, BioInformatics LLC uses sophisticated statistical analysis, including a Brand Equity Assessment and Van Westendorp Price Sensitivity Analysis, to provide a thorough and nuanced analysis of market dynamics. Results highlight a set of strategic leverage points to assist any competitor in maintaining dominance or gaining share in the reverse transcriptase market.

Included in the report are

-- Comparative assessment of each leading brand’s performance, both past and future
-- Breakdown of key elements that contribute to brand performance
-- Examination of the relationship between price and performance
-- Critical factors placing suppliers at risk for losing customers to competitors
-- Comprehensive assessment of market expectations